The trial is tied to a post-marketing commitment that FDA Commissioner Martin Makary put in place last year for all approved ...
By Bhanvi Satija LONDON, April 1 (Reuters) - Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated ...
16hon MSN
'Felt like I was dying': Elon Musk supports Pfizer insider who said Covid vaccine killed thousands
Sterz also cited figures from Germany’s vaccine safety monitoring system, managed by the Paul-Ehrlich-Institut, stating that ...
Pfizer BioNTech halt COVID vaccine study in adults 50-64 due to slow enrollment, citing inability to generate relevant postmarketing data.
COVID-19 partners Pfizer and BioNTech have been unable to recruit healthy adults aged 50 to 64 fast enough to deliver ...
Vaccine maker's critics hope for new attorney general to reverse Pam Bondi's hostility to clinical trial whistleblower's ...
The German biotechnology company currently employs 85 people at its manufacturing plant in Tuas.
The 2025-2026 COVID-19 vaccine formulation targets the SARS-CoV-2 sublineage LP.8.1, in line with FDA guidance to more closely match circulating strains 1 Shipping of the LP.8.1-adapted vaccine will ...
BioNTech will wind up its vaccine manufacturing plant in Singapore by February 2027 after a strategic review. Read more at ...
Pfizer and BioNTech have stopped their large U.S. COVID-19 vaccine trial in adults aged 50 to 64, citing insufficient ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results